These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 29296343)

  • 1. Clinical outcomes following image-guided stereotactic body radiation for pulmonary oligometastases.
    Kim D; Fuster MM; Nath SK; Bharne A; Read W; Bazhenova L; Song WY; Mundt AJ; Sandhu AP
    J Radiosurg SBRT; 2012; 2(1):63-72. PubMed ID: 29296343
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical outcomes following image-guided stereotactic body radiation for pulmonary oligometastases.
    Kim D; Fuster MM; Nath SK; Bharne A; Read W; Bazhenova L; Song WY; Mundt AJ; Sandhu AP
    J Radiosurg SBRT; 2012; 1(4):317-325. PubMed ID: 29296332
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and prognostic factors of stereotactic body radiotherapy combined with immunotherapy for pulmonary oligometastases: a preliminary retrospective cohort study.
    Piao MN; Xie J; Jin MM; Ma XT; Dou Z; Wang JP; Li JL
    Transl Lung Cancer Res; 2024 Aug; 13(8):1950-1963. PubMed ID: 39263027
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stereotactic body radiotherapy improves the survival of patients with oligometastatic non-small cell lung cancer.
    Ouyang W; Yu J; Nuerjiang S; Li Z; Wang D; Wang X; Zhang J; Xie C
    Cancer Med; 2019 Aug; 8(10):4605-4614. PubMed ID: 31245933
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic Factors and Optimal Response Interval for Stereotactic Body Radiotherapy in Patients With Lung Oligometastases or Oligoprogression From Colorectal Cancer.
    Li S; Dong D; Geng J; Zhu X; Shi C; Zhang Y; Wang H; Zhou S; Wu H; Cai Y; Li Y; Wang W
    Front Oncol; 2019; 9():1080. PubMed ID: 31681609
    [No Abstract]   [Full Text] [Related]  

  • 6. Extracranial Stereotactic Body Radiotherapy in Oligometastatic or Oligoprogressive Breast Cancer.
    Weykamp F; König L; Seidensaal K; Forster T; Hoegen P; Akbaba S; Mende S; Welte SE; Deutsch TM; Schneeweiss A; Debus J; Hörner-Rieber J
    Front Oncol; 2020; 10():987. PubMed ID: 32676455
    [No Abstract]   [Full Text] [Related]  

  • 7. Stereotactic body radiotherapy (SBRT) for medically inoperable lung metastases-A pooled analysis of the German working group "stereotactic radiotherapy".
    Rieber J; Streblow J; Uhlmann L; Flentje M; Duma M; Ernst I; Blanck O; Wittig A; Boda-Heggemann J; Krempien R; Lohaus F; Klass ND; Eble MJ; Imhoff D; Kahl H; Petersen C; Gerum S; Henkenberens C; Adebahr S; Hass P; Schrade E; Wendt TG; Hildebrandt G; Andratschke N; Sterzing F; Guckenberger M
    Lung Cancer; 2016 Jul; 97():51-8. PubMed ID: 27237028
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Stereotactic body radiation therapy for patients with lung and liver oligometastases from colorectal cancer: a phase Ⅱ trial].
    Lei JQ; Liu WY; Tang Y; Tang Y; Li N; Ren H; Yihebali C; Sun YK; Zhang W; Bi XY; Zhao JJ; Fang H; Lu NN; Zhou AP; Wang SL; Song YW; Liu YP; Chen B; Qi SN; Cai JQ; Li YX; Jin J
    Zhonghua Zhong Liu Za Zhi; 2022 Mar; 44(3):282-290. PubMed ID: 35316879
    [No Abstract]   [Full Text] [Related]  

  • 9. Stereotactic body radiotherapy for pulmonary oligometastases: a monoinstitutional analysis of clinical outcomes and potential prognostic factors.
    Cuccia F; Mazzola R; Figlia V; Giaj-Levra N; Nicosia L; Ricchetti F; Rigo M; Attinà G; Vitale C; Pastorello E; Ruggieri R; Alongi F
    Strahlenther Onkol; 2022 Oct; 198(10):934-939. PubMed ID: 35499694
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical Outcomes of Stereotactic Body Radiotherapy (SBRT) for Oligometastatic Patients with Lymph Node Metastases from Gynecological Cancers.
    Facondo G; Vullo G; De Sanctis V; Rotondi M; Sigillo RC; Valeriani M; Osti MF
    J Pers Med; 2023 Jan; 13(2):. PubMed ID: 36836463
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Short-Term Outcomes and Clinical Efficacy of Stereotactic Body Radiation Therapy (SBRT) for Oligometastases of Prostate Cancer in China.
    Xu C; Zhao X; Ju X; Shen Y; Qu M; Ye Y; Wang X; Yu C; Gao X; Zhang H
    Front Oncol; 2022; 12():879310. PubMed ID: 35574331
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A single-institution study of stereotactic body radiotherapy for patients with unresectable visceral pulmonary or hepatic oligometastases.
    Fumagalli I; Bibault JE; Dewas S; Kramar A; Mirabel X; Prevost B; Lacornerie T; Jerraya H; Lartigau E
    Radiat Oncol; 2012 Sep; 7():164. PubMed ID: 23014094
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stereotactic body radiotherapy in the management of oligometastatic and recurrent biliary tract cancer: single-institution analysis of outcome and toxicity.
    Franzese C; Bonu ML; Comito T; Clerici E; Loi M; Navarria P; Franceschini D; Pressiani T; Rimassa L; Scorsetti M
    J Cancer Res Clin Oncol; 2020 Sep; 146(9):2289-2297. PubMed ID: 32524292
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Survival and prognostic factors of pulmonary oligometastases treated with stereotactic body radiotherapy.
    Sharma A; Duijm M; Oomen-de Hoop E; Aerts JG; Verhoef C; Hoogeman M; Nuyttens JJ
    Acta Oncol; 2019 Jan; 58(1):74-80. PubMed ID: 30280633
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stereotactic Body Radiotherapy for Extracranial Oligometastatic Disease from Head and Neck Primary Cancers: A Systematic Review and Meta-Analysis.
    Mutsaers A; Akingbade A; Louie AV; Id Said B; Zhang L; Poon I; Smoragiewicz M; Eskander A; Karam I
    Cancers (Basel); 2024 Feb; 16(5):. PubMed ID: 38473213
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analyses of local control and survival after stereotactic body radiotherapy for pulmonary oligometastases from colorectal adenocarcinoma.
    Yamamoto T; Niibe Y; Matsumoto Y; Onishi H; Aoki M; Nishikawa A; Oh RJ; Shintani T; Yahara K; Ozaki M; Manabe Y; Jingu K
    J Radiat Res; 2020 Nov; 61(6):935-944. PubMed ID: 32940330
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outcomes of extra-cranial stereotactic body radiotherapy for metastatic breast cancer: Treatment indication matters.
    Tan H; Cheung P; Louie AV; Myrehaug S; Niglas M; Atenafu EG; Chu W; Chung HT; Poon I; Sahgal A; Soliman H
    Radiother Oncol; 2021 Aug; 161():159-165. PubMed ID: 34119585
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Survival, Treatment Outcome, and Safety of Multiple and Repeated Courses of Stereotactic Body Radiotherapy for Pulmonary Oligometastases of Head and Neck Squamous Cell Carcinoma.
    Vorbach SM; Mangesius J; Dejaco D; Seppi T; Santer M; Zur Nedden S; Sarcletti MP; Pointner MJ; Hart TJ; Riechelmann H; Ganswindt U; Nevinny-Stickel M
    Cancers (Basel); 2023 Nov; 15(21):. PubMed ID: 37958426
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-Term Outcomes of Stereotactic Body Radiotherapy (SBRT) for Intraprostatic Relapse after Definitive Radiotherapy for Prostate Cancer: Patterns of Failure and Association between Volume of Irradiation and Late Toxicity.
    Miszczyk M; Kraszkiewicz M; Moll M; Kaminiów K; Sobel S; Dolla Ł; Wojcieszek P; Rajwa P; Yanagisawa T; Nowicka Z; Shariat SF; Goldner G; Miszczyk L; Majewski W
    Cancers (Basel); 2023 Feb; 15(4):. PubMed ID: 36831523
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recursive partitioning model-based analysis for survival of colorectal cancer patients with lung and liver oligometastases treated with stereotactic body radiation therapy.
    Franzese C; Comito T; Franceschini D; Loi M; Clerici E; Navarria P; De Rose F; Di Brina L; Mancosu P; Reggiori G; Tomatis S; Scorsetti M
    J Cancer Res Clin Oncol; 2020 May; 146(5):1227-1234. PubMed ID: 32056005
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.